Journal of Clinical Oncology: “High biomarkers of inflammation are associated with reduced survival in breast cancer patients.”
International Journal of Environmental and Public Health Research: “Inflammatory Biomarkers and Breast Cancer Risk: A Systematic Review of the Evidence and the Future Potential of Intervention Research.”
Current pharmaceutical design: “Inflammation fuels tumor progression and metastasis.”
Cynthia Lynch, MD, medical oncologist, clinical advisor for the breast cancer program, Cancer Treatment Centers of America, Phoenix, AZ.
Naoto Tada Ueno, MD, PhD, Section Head, Translational Breast Cancer Research, Medical Breast Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.
Oncotarget: “Inflammatory responses and diseases associated with inflammation in organs.”
Tina J. Hieken, MD, surgical oncologist, Mayo Clinic; professor of surgery, Mayo Clinic College of Medicine, Rochester, MN.
Scientific reports: “The microbiome of human breast tissue taken aseptically in benign and malignant diseases.”
Molecules: “The microbiome and its implications in cancer immunotherapy.”
The Center for Ecogenetics and Environmental Health, University of Washington: “Fast Facts About the Human Microbiome”.
Johns Hopkins Medicine: “Faecal Transplantation (Bacteriotherapy)”.
Press release, Australian Science Media Center Inc.
National Center for Biotechnology Information: “StatPearls: Chronic Inflammation”.
Mayo Clinic: “How Much Should the Average Adult Make Each Day?”
American Cancer Society: “Alcohol Use and Cancer”.
PLOS ONE: “The association between smoking and inflammation: a study by the Genetic Arteriopathy Epidemiology Network (GENOA).”
Scripps Health: “Six Keys to Reducing Inflammation.”